
Health supplement targets glaucoma
Guardion Health Sciences has launched GlaucoCetin, a supplement shown in a small clinical trial to positively affect the optic nerve cells in glaucoma patients.Created by Dr Robert Ritch of New York

Guardion Health Sciences has launched GlaucoCetin, a supplement shown in a small clinical trial to positively affect the optic nerve cells in glaucoma patients.Created by Dr Robert Ritch of New York

New Zealander Steve Stenersen is the only southern hemisphere optician in the running for the 2019 IOA/Silmo Optician of the Year title to be announced at the annual Paris event this

All University of Auckland first year students can now take a general course in human vision.Convened by Associate Professor Sam Schwarzkopf, Professor Steven Dakin and Dr Misha Vorobyev, the new

FDA approval has been granted for Soliris injections to treat neuromyelitis optica spectrum disorder (NMOSD), an autoimmune disease of the central nervous system that affects the optic nerves and

Trials of a new acuity testing device have successfully increased health study participation rates among Māori.Dr Jason Turuwhenua, from Auckland University’s Bioengineering Institute and Ngāi Tūhoe

EssilorLuxottica intends to acquire full ownership of GrandVision ‘to create a truly global eyecare and eyewear company’, adding €3.7 billion to its annual revenue.The acquisition will see the global


The New Zealand Optical Wholesalers Association’s (NZOWA’s) future hangs in the balance after Gary Edgar reluctantly stepped down as president of the 40-year-old organisation with no one named to repl


The Australian Government is improving the Consumer Medicine Information (CMI) given to patients after doctors and consumer health advocates raised concerns regarding the complexity and readability of


Adidas, from Silhouette to Marcolin